Join the Anaphylaxis group to help and get support from people like you.
Anaphylaxis News (Page 4)
Related terms: Anaphylactic Reaction, Anaphylactic Shock, Shock, Anaphylactic
More Parents Are Introducing Peanuts Early
MONDAY, July 31, 2023 – Early peanut feeding practices are gaining traction among U.S. parents/caregivers, according to a study published online July 21 in Pediatrics. Waheeda Samady, M.D., from the...
Direct Oral Penicillin Challenge Noninferior to Standard of Care
TUESDAY, July 25, 2023 – For patients with low-risk penicillin allergy, direct oral penicillin challenge is noninferior to standard-of-care skin testing followed by oral challenge, according to a...
Maternal Egg Consumption Not Tied to Egg Allergy in Offspring
THURSDAY, July 13, 2023 – Development of egg allergy at 12 months is unaffected by maternal egg consumption during the very early neonatal period, according to a study published July 10 in JAMA N...
Are Your Allergies Ready to Head Off to College?
WEDNESDAY, July 5, 2023 – As you stare down your freshman year of college and contemplate living away from home, you’re probably facing a few “firsts”: First roommate who isn’t a sibling; first time ...
FDA Approves Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] as First Treatment for Peanut Allergy
BRISBANE, Calif.--(BUSINESS WIRE)--Jan. 31, 2020-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening...
FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals that Some EpiPen Auto-Injectors May Not Readily Slide Out of Carrier Tube
[11/2/2018] FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions,...
Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi Product
SAN DIEGO, Sept. 27, 2018 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ lower...
FDA Approves Kaléo’s Auvi-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
Richmond, VA (November 20, 2017) kaléo, a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application ...
Adamis Pharmaceuticals Receives FDA Approval for Symjepi (epinephrine) Pre-Filled Syringe
SAN DIEGO, June 15, 2017 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) (“Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ EPINEP...
FDA Medwatch Alert: EpiPen and and EpiPen Jr Auto-Injector: Recall - Failure to Activate Device
ISSUE: Mylan N.V. announced that Meridian Medical Technologies, a Pfizer company and Mylan’s manufacturing partner for EpiPen Auto-Injector, has expanded a voluntary recall of select lots of EpiPen (...
FDA Medwatch Alert: Auvi-Q (epinephrine injection, USP): Recall - Potential Inaccurate Dosage Delivery
ISSUE: Sanofi US is voluntarily recalling all Auvi-Q (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for...
Sanofi Announces FDA Approval for Auvi-Q, First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies
PARIS, Aug. 13, 2012 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) has approved Audi-Q (epinephrine injection, USP) for the emergency treatment of...
Ask a question
To post your own question to this support group, sign in or create an account.